Dna X (SONM) Total Non-Current Liabilities (2018 - 2026)

Dna X has reported Total Non-Current Liabilities for 9 years, with the latest figure at $4.5 million in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 87.17% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (down 87.17% YoY), and the FY2025 full-year result was $50.5 million, up 15.35% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $4.5 million, down from $50.5 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $50.5 million in Q4 2025, with the low at $4.5 million in Q1 2026.
• Historically, Total Non-Current Liabilities has averaged $31.0 million across 5 years, with a median of $32.1 million in 2023.
• Annual changes were most pronounced in 2025 — Total Non-Current Liabilities surged 68.02% — and 2026, when it slumped 87.17%.
• Dna X's Total Non-Current Liabilities stood at $32.2 million in 2022, then retreated by 0.2% to $32.1 million in 2023, then jumped by 36.06% to $43.7 million in 2024, then advanced by 15.35% to $50.5 million in 2025, then plunged by 91.04% to $4.5 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $4.5 million (Q1 2026), $50.5 million (Q4 2025), and $39.1 million (Q3 2025), per Business Quant data.